AMP (Amgen Molecular Pathways)

AMP, or Amgen Molecular Pathways, is a program developed by Amgen, a biotechnology company. It focuses on understanding and mapping cellular pathways involved in diseases, particularly cancer. By examining how cells communicate and respond to various signals, AMP helps identify new targets for drug development, enabling more effective and personalized treatments. This approach aims to enhance the understanding of disease mechanisms, ultimately leading to better therapeutic options for patients by tailoring treatments based on the specific molecular characteristics of their conditions.